JCR Pharmaceuticals Co Ltd
F:JCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
JCR Pharmaceuticals Co Ltd
F:JCR
|
JP |
|
Roots Corp
TSX:ROOT
|
CA |
Intrinsic Value
The intrinsic value of JCR Pharmaceuticals Co Ltd (JCR) under the Base Case is 0.56 EUR per share. Compared with the current market price of 2.94 EUR, the stock appears Overvalued by 81% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What JCR Pharmaceuticals Does
JCR Pharmaceuticals is a Japanese pharmaceutical company that develops and sells specialty medicines, with a strong focus on rare diseases and diseases tied to the body’s protein and enzyme systems. Its best-known products include treatments for conditions such as growth hormone deficiency, Fabry disease, and other hard-to-treat metabolic and neurological disorders. The company also works on cell and gene therapy, which aims to treat disease at a deeper biological level than standard drugs.
- Headquarters
- Japan JP
- Employees
- 987
- IPO date
- Mar 16, 1995
Revenue & Expenses Breakdown
JCR Pharmaceuticals Co Ltd
Earnings Waterfall
JCR Pharmaceuticals Co Ltd
The intrinsic value for JCR Pharmaceuticals Co Ltd (JCR) under the Base Case is 0.56 EUR.
Compared with the current market price of 2.94 EUR, the stock appears Overvalued by 81% .